Joan Johnson

FDA investigator

Appears on 2 documents from 2017 to 2019, mostly at sites in Canada. Most often cites written procedures; deviations (21 CFR 211.100).

2
Documents on file
1.5
Observations per 483
2017
First seen
2019
Most recent

What they cite most

From 3 observations

Activity by year

2017: 1, 2019: 1

Where

Canada 1 · New Jersey 1

Often inspects with

Anita Verma· Ashley Burns· Denise Gavin

Is Joan Johnson coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 Sanofi Pasteur LimitedOct 11, 2019 · North York, Canada
483 Novartis Pharmaceuticals CorporationApr 7, 2017 · Morris Plains, New Jersey

About this profile

What does Joan Johnson inspect?

Joan Johnson appears on 2 documents on file covering 2 sites, mostly in Canada.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.56.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Joan Johnson is dated Oct 11, 2019.

FDA Investigator Joan Johnson: 483s & Inspections · FDA Intel